Liposomal Dendritic Cell Vaccine in Breast Cancer Immunotherapy
| Published in: | ACS Omega |
|---|---|
| Main Authors: | Hong Pan, Hongyan Shi, Peng Fu, Pengfei Shi, Jianyuan Yang |
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2021-01-01
|
| Online Access: | https://doi.org/10.1021/acsomega.0c05924 |
Similar Items
Dendritic cell-targeted liposomes for cancer immunotherapy via inhibition of aryl hydrocarbon receptor
by: Chen-Guang Zhang, et al.
Published: (2025-10-01)
by: Chen-Guang Zhang, et al.
Published: (2025-10-01)
Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance
by: Noémi Anna Nagy, et al.
Published: (2021-05-01)
by: Noémi Anna Nagy, et al.
Published: (2021-05-01)
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
by: João Calmeiro, et al.
Published: (2020-02-01)
by: João Calmeiro, et al.
Published: (2020-02-01)
Plasmacytoid Dendritic Cells and Cancer Immunotherapy
by: Chunmei Fu, et al.
Published: (2022-01-01)
by: Chunmei Fu, et al.
Published: (2022-01-01)
Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
by: Chen Shi, et al.
Published: (2023-09-01)
by: Chen Shi, et al.
Published: (2023-09-01)
Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01)
by: I.Yu. Filin, et al.
Published: (2022-09-01)
Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy
by: Komal Kumari, et al.
Published: (2024-05-01)
by: Komal Kumari, et al.
Published: (2024-05-01)
Endotoxemia in immunotherapy with dendritic cell vaccine in patients with advanced cervical cancer
by: I. A. Goroshinskaya, et al.
Published: (2022-06-01)
by: I. A. Goroshinskaya, et al.
Published: (2022-06-01)
A dendritic cell vaccine for both vaccination and neoantigen-reactive T cell preparation for cancer immunotherapy in mice
by: Qing Li, et al.
Published: (2024-11-01)
by: Qing Li, et al.
Published: (2024-11-01)
Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
by: Chen Shi, et al.
Published: (2023-11-01)
by: Chen Shi, et al.
Published: (2023-11-01)
Impact of Chitosan Nanoparticles-Coated Dendritic Cell-Based Vaccine as Cancer Immunotherapy
by: Jehan S. Alrahimi, et al.
Published: (2025-04-01)
by: Jehan S. Alrahimi, et al.
Published: (2025-04-01)
Cryogel‐Based Dendritic Cell Immunotherapy for Post‐Surgical Breast Cancer Treatment
by: Lam‐Duc‐Huy Nguyen, et al.
Published: (2025-10-01)
by: Lam‐Duc‐Huy Nguyen, et al.
Published: (2025-10-01)
Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy
by: Natacha Jugniot, et al.
Published: (2022-10-01)
by: Natacha Jugniot, et al.
Published: (2022-10-01)
The Efficacy of Neoantigen-Loaded Dendritic Cell Vaccine Immunotherapy in Non-Metastatic Gastric Cancer
by: Menelaos Papakonstantinou, et al.
Published: (2025-07-01)
by: Menelaos Papakonstantinou, et al.
Published: (2025-07-01)
Cytokine-overexpressing dendritic cells for cancer immunotherapy
by: Joonsu Han, et al.
Published: (2024-12-01)
by: Joonsu Han, et al.
Published: (2024-12-01)
Dendritic Cell-Based Immunotherapy for Prostate Cancer
by: Hanka Jähnisch, et al.
Published: (2010-01-01)
by: Hanka Jähnisch, et al.
Published: (2010-01-01)
Dendritic cell subsets and implications for cancer immunotherapy
by: Michael Y. Chen, et al.
Published: (2024-06-01)
by: Michael Y. Chen, et al.
Published: (2024-06-01)
DNA sensing of dendritic cells in cancer immunotherapy
by: Wei Qian, et al.
Published: (2024-05-01)
by: Wei Qian, et al.
Published: (2024-05-01)
Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
by: Shumin Luo, et al.
Published: (2023-08-01)
by: Shumin Luo, et al.
Published: (2023-08-01)
GLS and GOT2 as prognostic biomarkers associated with dendritic cell and immunotherapy response in breast cancer
by: Ruifang Yang, et al.
Published: (2024-01-01)
by: Ruifang Yang, et al.
Published: (2024-01-01)
Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
by: Ping Zhu, et al.
Published: (2023-06-01)
by: Ping Zhu, et al.
Published: (2023-06-01)
In Situ Dendritic Cell Recruitment and T Cell Activation for Cancer Immunotherapy
by: Joonsu Han, et al.
Published: (2022-08-01)
by: Joonsu Han, et al.
Published: (2022-08-01)
Murine Dendritic Cells for Immunotherapy and Vaccine Development: Generation, Optimization and Transduction
by: Mona Sadat Larijani, et al.
Published: (2020-12-01)
by: Mona Sadat Larijani, et al.
Published: (2020-12-01)
Dendritic Cell-Based Immunotherapy: The Importance of Dendritic Cell Migration
by: Min-Seon Song, et al.
Published: (2024-01-01)
by: Min-Seon Song, et al.
Published: (2024-01-01)
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
by: Heng Dong, et al.
Published: (2023-06-01)
by: Heng Dong, et al.
Published: (2023-06-01)
IMMUNOTHERAPY BASED ON DENDRITIC CELLS IN BLADDER CANCER TREATMENT
by: A. S. Ilnitskaya, et al.
Published: (2018-07-01)
by: A. S. Ilnitskaya, et al.
Published: (2018-07-01)
Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells
by: Oscar Badillo, et al.
Published: (2024-04-01)
by: Oscar Badillo, et al.
Published: (2024-04-01)
The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
by: Elena V. Abakushina, et al.
Published: (2021-11-01)
by: Elena V. Abakushina, et al.
Published: (2021-11-01)
Homologous targeted neutrophils-liposome system for pyroptosis-enhanced antitumor immunotherapy of triple-negative breast cancer
by: Ge Gao, et al.
Published: (2025-06-01)
by: Ge Gao, et al.
Published: (2025-06-01)
Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation
by: Simone P. Sittig, et al.
Published: (2015-12-01)
by: Simone P. Sittig, et al.
Published: (2015-12-01)
Preparation and effects of functionalized liposomes targeting breast cancer tumors using chemotherapy, phototherapy, and immunotherapy
by: Bowen Zeng, et al.
Published: (2024-09-01)
by: Bowen Zeng, et al.
Published: (2024-09-01)
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
by: Shanshan Cheng, et al.
Published: (2020-04-01)
by: Shanshan Cheng, et al.
Published: (2020-04-01)
Dendritic Cell-Derived Exosomes: Next Generation of Cancer Immunotherapy
by: Rajib Dhar, et al.
Published: (2025-10-01)
by: Rajib Dhar, et al.
Published: (2025-10-01)
Understanding Dendritic Cells and Their Role in Cutaneous Carcinoma and Cancer Immunotherapy
by: Valerie R. Yanofsky, et al.
Published: (2013-01-01)
by: Valerie R. Yanofsky, et al.
Published: (2013-01-01)
Dendritic Cell Immunotherapy for Ovarian Cancer: An Overview of Our Achievements
by: Jiřina Bartůňková
Published: (2024-03-01)
by: Jiřina Bartůňková
Published: (2024-03-01)
Dendritic Cell as Potential Immunotherapy for Nasopharyngeal Cancer: A Review
by: Albertus Budi Sulistya, et al.
Published: (2023-10-01)
by: Albertus Budi Sulistya, et al.
Published: (2023-10-01)
The Role of STING-Mediated Activation of Dendritic Cells in Cancer Immunotherapy
by: Ribeiro AR, et al.
Published: (2024-10-01)
by: Ribeiro AR, et al.
Published: (2024-10-01)
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
by: Raquel S Laureano, et al.
Published: (2022-12-01)
by: Raquel S Laureano, et al.
Published: (2022-12-01)
Advances in Non-Small Cell Lung Cancer Cellular Immunotherapy: A Progress in Dendritic Cell, T-Cell, and NK Cell Vaccines
by: Mirza Masroor Ali Beg, et al.
Published: (2025-09-01)
by: Mirza Masroor Ali Beg, et al.
Published: (2025-09-01)
Cancer Vaccine by Fusions of Dendritic and Cancer Cells
by: Shigeo Koido, et al.
Published: (2009-01-01)
by: Shigeo Koido, et al.
Published: (2009-01-01)
Similar Items
-
Dendritic cell-targeted liposomes for cancer immunotherapy via inhibition of aryl hydrocarbon receptor
by: Chen-Guang Zhang, et al.
Published: (2025-10-01) -
Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance
by: Noémi Anna Nagy, et al.
Published: (2021-05-01) -
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
by: João Calmeiro, et al.
Published: (2020-02-01) -
Plasmacytoid Dendritic Cells and Cancer Immunotherapy
by: Chunmei Fu, et al.
Published: (2022-01-01) -
Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
by: Chen Shi, et al.
Published: (2023-09-01)
